Page 1 of Clinical Trials for Astellas Pharma Europe BV [SPONSOR-COLLABORATORS], 15 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Not yet recruiting
A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug
Last Updated: March 27, 2012
Condition(s): Urinary Bladder; Overactive
2
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Alone and in Combination for the Treatment of Overactive Bladder
Last Updated: April 9, 2012
Condition(s): Urinary Bladder, Overactive; Urinary Bladder Diseases; Urologic Diseases; Urological Manifestations; Signs and Symptoms
3
Completed
Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder
Last Updated: May 22, 2012
Condition(s): Urinary Bladder, Overactive
4
Recruiting
To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis
Last Updated: April 4, 2012
Condition(s): Clostridium Difficile
5
Completed
A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects
Last Updated: April 17, 2012
Condition(s): Pharmacokinetics; Healthy Subjects; Mild and Moderate Hepatic Impairment
6
Not yet recruiting
A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Patients 5 to 18 Years of Age With Neurogenic Detrusor Overactivity
Last Updated: March 27, 2012
Condition(s): Neurogenic Detrusor Overactivity
7
Completed
Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.
Last Updated: December 9, 2008
Condition(s): Kidney Transplantation
8
Completed
A Study of YM060 in Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS)
Last Updated: April 15, 2008
Condition(s): Irritable Bowel Syndrome
9
Completed
Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
Last Updated: April 15, 2008
Condition(s): Asthma, Bronchial; Bronchial Asthma
10
Completed
A Study to Evaluate FK778 in Kidney Transplant Patients
Last Updated: April 15, 2008
Condition(s): Kidney Transplantation; Renal Transplantation; Transplantation, Renal; Transplantation, Kidney; Grafting, Kidney
11
Completed
A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)
Last Updated: December 2, 2008
Condition(s): Overactive Bladder; Urinary Incontinence; Urge Incontinence
12
Completed
A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.
Last Updated: July 9, 2008
Condition(s): Benign Prostatic Hyperplasia
13
Completed
Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)
Last Updated: January 11, 2010
Condition(s): Thromboembolism
14
Completed
Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma
Last Updated: April 15, 2008
Condition(s): Asthma, Bronchial; Bronchial Asthma
15
Completed
A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)
Last Updated: April 15, 2008
Condition(s): Overactive Bladder

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Astellas+Pharma+Europe+BV

Page 1 of Clinical Trials for Astellas Pharma Europe BV [SPONSOR-COLLABORATORS], 15 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About